ALEXANDRIA GARLOW: Open Payments
NPI 1982218582 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 10 companies in 2025. Trend: 2023 $1,333 · 2024 $417 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $89 |
| Exeltis, USA Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Biogen, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| MILLICENT US INC | 2 | $36 |
| CooperSurgical, Inc. | 1 | $17 |
| Provepharm Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Organon LLC | 1 | $8 |
Products named: Veozah, SLYND, MYFEMBREE, ZURZUVAE, Lynkuet, FEMRING, Mirena, Paragard T 380A.
Industry payments across VA — which companies pay providers there.
